Attached files
| file | filename |
|---|---|
| EX-4.3 - EX-4.3 - Timber Pharmaceuticals, Inc. | a2228403zex-4_3.htm |
| EX-10.13 - EX-10.13 - Timber Pharmaceuticals, Inc. | a2228403zex-10_13.htm |
| EX-31.1 - EX-31.1 - Timber Pharmaceuticals, Inc. | a2228403zex-31_1.htm |
| EX-31.2 - EX-31.2 - Timber Pharmaceuticals, Inc. | a2228403zex-31_2.htm |
| EX-21.1 - EX-21.1 - Timber Pharmaceuticals, Inc. | a2228403zex-21_1.htm |
| 10-K - 10-K - Timber Pharmaceuticals, Inc. | a2228403z10-k.htm |
| EX-32.1 - EX-32.1 - Timber Pharmaceuticals, Inc. | a2228403zex-32_1.htm |
QuickLinks -- Click here to rapidly navigate through this document
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-201708) and the Registration Statement on Form S-3 (No. 333-209026) of BioPharmX Corporation of our report dated May 2, 2016 relating to the consolidated financial statements, which appears in this Annual Report on Form 10-K.
/s/ Burr Pilger Mayer, Inc.
San
Jose, California
May 2, 2016
Consent of Independent Registered Public Accounting Firm